PRICE T ROWE ASSOCIATES INC /MD/ - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5
+66.7%
33,9590.0%0.00%
Q4 2022$3
-99.9%
33,959
+89.1%
0.00%
Q3 2022$3,000
-96.2%
17,954
-79.9%
0.00%
Q2 2022$79,000
-28.2%
89,354
+1.1%
0.00%
Q1 2022$110,000
-33.3%
88,371
+4.7%
0.00%
Q4 2021$165,000
+7.8%
84,371
+51.0%
0.00%
Q3 2021$153,000
-14.5%
55,871
-1.6%
0.00%
Q2 2021$179,000
+113.1%
56,771
+43.7%
0.00%
Q1 2021$84,00039,5000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$32,135,00011.34%
VR Adviser, LLC 16,047,286$43,970,0005.65%
COMMODORE CAPITAL LP 5,123,509$14,038,0003.70%
Ghost Tree Capital, LLC 2,000,000$5,480,0001.60%
EPIQ PARTNERS, LLC 916,100$2,510,0001.16%
SILVERARC CAPITAL MANAGEMENT, LLC 707,733$1,939,0001.10%
SPHERA FUNDS MANAGEMENT LTD. 3,824,938$10,480,0000.88%
HighVista Strategies LLC 438,239$1,201,0000.80%
Nicholas Investment Partners, LP 2,786,354$7,635,0000.56%
NEA Management Company, LLC 16,302,596$44,669,0000.53%
View complete list of VISTAGEN THERAPEUTICS INC shareholders